Idea Cellular slumps post Q4FY16 earnings

Shriram Trans Q4: Net Profit at Rs144 Cr

Shriram Trans Q4: Net Profit at Rs144 Cr: Shriram Tran 927.75 -3.79% NII at Rs1,475 Cr

Total Income at Rs2918 Cr Vs Rs2312.33 Cr (YoY)

FY16 net profit at Rs1178.20 Cr vs Rs1237.81 Cr (YoY)

FY16 total income at Rs10245.26 Cr vs Rs8644.73 Cr (YoY)

ICICI Bank Q4FY16 results: Asset quality deteriorates

ICICI bank has reported deteriorated asset quality for Q4FY16 as G NPA rose by 110 BPS to 5.82% QoQ as accounts worth around Rs7000 crore slipped into NPA, however RBI’s AQR has been completely taken into account.

The Bank reported a modest 6.4% growth in Net interest income while the non interest income was up by 46.1% YoY. Provisions rose sharply by 147.4% YoY owing to Rs3600 crore additional contingent provisioning done during the quarter.

Profit during the quarter came in at Rs702 crore (down 76% YoY) owing to higher provisioning. We currently have a hold rating on the stock and would come out with detailed note post management interaction.

Lupin surges on re-introducing Methergine Oral Tablets

Lupin rose over 2%, touching to Rs1617.65, after the company announced that its US subsidiary has re-introduced Methergine (methylergonovine maleate) Oral Tablets 0.2mg in the US for the prevention and management of postpartum hemorrhage.

Lupin and its US subsidiary, Lupin Pharmaceuticals, Inc. have announced the re-introduction of Methergine (methylergonovine maleate) Oral Tablets 0.2mg in the US for the prevention and management of postpartum hemorrhage (PPH). Methergine is the only FDA-approved oral uterotonic and is a preferred oral agent in the management of PPH, according to guidelines issued by the American Congress of Obstetricians and Gynecologists (ACOG).

Idea Cellular slumps post Q4FY16 earnings

Shares of Idea Cellular slumped 6% to Rs119.35 on NSE post Q4FY16 earnings which beat estimates but share price fell as volume growth remained soft.

Idea cellular posted strong operational performance, its operating profit grew by 15.6% on a sequential basis, backed by pricing growth in voice (+4.7% qoq) as well as data(+2.7% qoq) segment, but the growth volume growth tapered for both the segments at 1.2% and 1.5% qoq).Higher depreciation & interest cost resulted in 24.7% qoq decline in net earnings.

Ajanta Pharma Q4 consolidated net profit up 43% (YoY)

Ajanta Pharma has announced the following audited Q4 & FY16 results for the quarter & year ended March 31, 2016:

Standalone (YoY)

For the Quarter ended March 31, 2016

The Company has posted a net profit of Rs135.71 crore Vs Rs84.31 crore.

Total Income increased to Rs443.26 crore Vs Rs371.68 crore.

Our Some Best Services Read it Here…

Commodity Market Tips, MCX Copper Tips, MCX Tips, Crude oil tips, Nifty Options Tips, Share Market Live, Financial Advisory Company in Indore, Stock Advisory Company in Indore

 CapitalStars Financial Research Financial Advisory Services 

www.capitalstars.com | T:+91-731-6790000,6669900

TOP CORPORATE NEWS- 28 Apr 2016

Dabur India Q4 consolidated net profit up 17% (YoY)

Dabur India has announced the following audited Q4 & FY16 results for the quarter & year ended March 31, 2016:

Standalone

For the Quarter ended March 31, 2016 (YoY)

The Company has posted a net profit of Rs289.03 crore Vs Rs212.94 crore.

Total Income increased to Rs1566.89 crore Vs Rs1429.21 crore.

DLF launches Mall of India at investment of Rs1700 croresa

DLF launches Mall of India (2 million sq ft built at an investment of Rs1700 crore) – Positive for DLF

As per media reports, DLF officially launched Mall of India in Noida. The mall built at an investment of Rs1700 crore is spread across 2 million square feet.

As much as 95% of the space in the mall has been leased out with as many as 14 anchor partners.

ACC Q1 consolidated net profit down 4% (YoY)

ACC Ltd has announced the following results for the quarter ended March 31, 2016

Standalone

For the Quarter ended March 31, 2016 (YoY)

The Company has posted a net profit of Rs232.19 crore Vs Rs240.55 crore.

Total Income has decreased to Rs3039.52 crore Vs Rs3139.22 crore.

Ceat Q4 consolidated net profit up 11% (YoY)

Ceat has announced the following Q4 & FY16 audited results for the quarter & year ended March 31, 2016:

Standalone

For the Quarter ended March 31, 2016 (YoY)

The Company has posted a net profit of Rs102.23 crore Vs Rs89.44 crore.

Total Income decreased to Rs1397.55 crore Vs Rs1431.77 crore.

Aurobindo gets tentative nod from USFDA for Tadalafil

Aurobindo gets tentative nod from USFDA to manufacture and market Tadalafil, used in treating erectile dysfunction and for treatment of pulmonary hypertension – Positive for Aurobindo.

Our Some Best Services Read it Here…

Commodity Market Tips, MCX Copper Tips, MCX Tips, Crude oil tips, Nifty Options Tips, Share Market Live, Financial Advisory Company in Indore, Stock Advisory Company in Indore

 CapitalStars Financial Research Financial Advisory Services 

www.capitalstars.com | T:+91-731-6790000,6669900

TOP CORPORATE NEWS- 27 Apr 2016

Alembic Pharma Q4: Cons Net Profit +29.6% at Rs91.2 Cr

Alembic Pharma Q4: Cons Net Profit +29.6% At Rs.91.2 Cr Vs Rs.70.3 Cr (YoY)

Cons Total Income +24.6% At Rs.626.6 Cr Vs Rs.503 Cr (YoY)

Cons EBITDA At Rs.143.3 Cr Vs Rs.98 Cr (YoY)

Cons EBITDA +46.3% At Rs.143.3 Cr Vs Rs.98 Cr (YoY)

India Generic Biz Revenue -46% At 17.4 Cr Vs Rs.32.1 Cr (YoY)

India Branded Biz Revenue +12% At 259.6 Cr Vs Rs.232.1 Cr (YoY)

Intl Biz Revenue +20% At 190.2 Cr Vs Rs.158.3 Cr (YoY)

Axis Bank drops post Q4FY16 results

Shares of Axis Bank dropped 3.4% to Rs464 on NSE post Q4FY16 result update where business growth remained healthy; Asset quality stable; PT revised to Rs590.

NII up 19.8%; Margins expand: Axis bank reported a strong 19.8% growth in Net interest for Q4FY16 owing to 20.5% jump in the advances and expansion in Net Interest Margins (up 16 BPS Yo and 18 BPS QoQ). Non-interest income growth was flat as treasury profit declined by 65.4% YoY, however retail fee income showed a growth of 15.1% YoY. Provisions for Q4FY16 surged by 64.6% YoY owing to Rs300 crore contingent provisions made during the quarter.

Yes Bank reports robust operating performance; Asset quality deteriorates

Yes Bank has announced the following audited Q4 & FY16 results for the quarter & year ended March 31, 2016:

Standalone

The Bank has posted a net profit of Rs702.11 crore Vs Rs550.99 crore (YoY).

Total Income increased to Rs4331.11 crore Vs Rs3678.83 crore (YoY).

M&M launches bigger variant of Bolero pick-up truck

M&M launches bigger variant of the Bolero pick-up truck; to further consolidate leadership in pick up category,M&M launched the new “Big Bolero” pick-up truck in two variants on with 1,250 Kg payload and the other with 1,500 Kg payload.

The pick-up is powered by the proven MDI Turbo charged engine. The vehicle is priced at Rs6.15 lakh (BS3 ex showroom Pune) and Rs6.3 lakh (BS4 ex-showroom Pune).

Aurobindo Pharma receives USFDA approval for Oxymorphone Tablets

Aurobindo Pharma receives USFDA Approval for Oxymorphone Hydrochloride Tablets – Positive for Aurobindo.

Aurobindo gets final approval from USFDA to manufacture and market Oxymorphone Hydrochloride Tablets, used to help relieve moderate to severe acute pain where the use of an opioid is appropriate.

The approved product has an estimated market size of US$ 55.5 million for the twelve months ending February 2016 according to IMS.

Our Some Best Services Read it Here…

Commodity Market Tips, MCX Copper Tips, MCX Tips, Crude oil tips, Nifty Options Tips, Share Market Live, Financial Advisory Company in Indore, Stock Advisory Company in Indore

 CapitalStars Financial Research Financial Advisory Services 

www.capitalstars.com | T:+91-731-6790000,6669900

TOP CORPORATE NEWS- 26 Apr 2016

Maruti Suzuki Q4 net profit down 12% to Rs1134 cr (YoY)

Maruti Suzuki India has announced the following Q4 & FY16 results for the quarter & year ended March 31, 2016:

Standalone

For the Quarter ended March 31, 2016 (Unaudited)

Net Profit falls by 11.72% to Rs1133.60 crore Vs Rs1284.20 crore (YoY).

Total Income increased by 10.62% to Rs15426.90 crore Vs Rs13944.70 crore (YoY).

M&M launches Scorpio Adventure at Rs13.07 lakh

M&M has launched the Scorpio Adventure Limited Edition utility vehicle at a price of Rs13.07 lakh (Ex-showroom pre-Octroi, Navi Mumbai) and is based on the top-of-the-line S10 variant of the existing Scorpio.

While the vehicle's interior remains unchanged, it looks slightly different from outside with Mist Silver and White dual-tone with adventure-themed decals, gun metal-finished alloy wheels and red brake callipers.

BPCL receives green nod for Rs694 crore project

BPCL has received green nod for its Rs694 crore project of developing LPG 1 mmpta import terminal as well as storage, bottling and bulk distribution facilities at Haldia Dock Complex in West Bengal.

Sun Pharma, Govt in PPP for malaria eradication

Sun Pharmaceuticals has entered into a public private partnership (PPP) with the Union and Madhya Pradesh governments for a campaign to ensure a malaria-free India.

In this partnership, the three stakeholders will establish a phased malaria eradication project for most endemic districts of Madhya Pradesh.

Moreover, the company and the Indian Council of Medical Research (ICMR) may enter a joint drug development programme to manufacture new patented drugs.

Hindalco up after Aditya to accept improved Metals X bid

Hindalco Industries has announced that it has communicated to Aditya Birla Minerals ( ABML) its intention to accept the improved offer by Metal X to acquire shares of ABML subject to receiving the approval of the Reserve Bank of India ( RBI) and no bona fide superior proposal being announced by a third party within 5 business days of Metals X announcing its intention to make the offer.

Metal X, a listed company in Australia has made an announcement regarding its intention to improve its ongoing takeover offer for acquiring shares of ABML under the relevant laws of Australia. ABML is a subsidiary of Hindalco Industries and listed on Australian Stock Exchange.

Our Some Best Services Read it Here…

Commodity Market Tips, MCX Copper Tips, MCX Tips, Crude oil tips, Nifty Options Tips, Share Market Live, Financial Advisory Company in Indore, Stock Advisory Company in Indore

 CapitalStars Financial Research Financial Advisory Services 

www.capitalstars.com | T:+91-731-6790000,6669900